147 related articles for article (PubMed ID: 9195961)
1. Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells.
Karas M; Danilenko M; Fishman D; LeRoith D; Levy J; Sharoni Y
J Biol Chem; 1997 Jun; 272(26):16514-20. PubMed ID: 9195961
[TBL] [Abstract][Full Text] [Related]
2. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
Bermont L; Fauconnet S; Lamielle F; Adessi GL
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
Kleinman D; Karas M; Danilenko M; Arbell A; Roberts CT; LeRoith D; Levy J; Sharoni Y
Endocrinology; 1996 Mar; 137(3):1089-95. PubMed ID: 8603578
[TBL] [Abstract][Full Text] [Related]
4. Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol.
Kleinman D; Karas M; Roberts CT; LeRoith D; Phillip M; Segev Y; Levy J; Sharoni Y
Endocrinology; 1995 Jun; 136(6):2531-7. PubMed ID: 7750475
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
6. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
Ricort JM; Binoux M
J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
[TBL] [Abstract][Full Text] [Related]
9. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action.
Mohseni-Zadeh S; Binoux M
Endocrinology; 1997 Dec; 138(12):5645-8. PubMed ID: 9389554
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding proteins as mediators of IGF-I effects on colon cancer cell proliferation.
Michell NP; Dent S; Langman MJ; Eggo MC
Growth Factors; 1997; 14(4):269-77. PubMed ID: 9386991
[TBL] [Abstract][Full Text] [Related]
14. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.
Grimberg A; Cohen P
J Cell Physiol; 2000 Apr; 183(1):1-9. PubMed ID: 10699960
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.
Kiepe D; Ulinski T; Powell DR; Durham SK; Mehls O; Tönshoff B
Kidney Int; 2002 Nov; 62(5):1591-600. PubMed ID: 12371959
[TBL] [Abstract][Full Text] [Related]
16. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
Devi GR; Graham DL; Oh Y; Rosenfeld RG
Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
Yee D; Jackson JG; Kozelsky TW; Figueroa JA
Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
Price WA; Moats-Staats BM; Stiles AD
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism.
Rajah R; Valentinis B; Cohen P
J Biol Chem; 1997 May; 272(18):12181-8. PubMed ID: 9115291
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells.
Attias-Geva Z; Bentov I; Ludwig DL; Fishman A; Bruchim I; Werner H
Eur J Cancer; 2011 Jul; 47(11):1717-26. PubMed ID: 21450456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
